News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
283,158 Results
Type
Article (15120)
Company Profile (299)
Press Release (267733)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (80126)
Career Advice (163)
Deals (13387)
Drug Delivery (39)
Drug Development (50892)
Employer Resources (31)
FDA (5900)
Job Trends (5227)
News (145682)
Policy (10136)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (944)
Accelerated approval (19)
Adcomms (14)
Allergies (81)
Alliances (21911)
ALS (124)
Alzheimer's disease (1030)
Antibody-drug conjugate (ADC) (241)
Approvals (6094)
Artificial intelligence (258)
Autoimmune disease (110)
Automation (9)
Bankruptcy (105)
Best Places to Work (4618)
BIOSECURE Act (6)
Biosimilars (100)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (45)
Breast cancer (346)
Cancer (3132)
Cardiovascular disease (237)
Career advice (148)
Career pathing (7)
CAR-T (217)
CDC (5)
Cell therapy (563)
Cervical cancer (14)
Clinical research (43817)
Collaboration (1153)
Company closure (2)
Compensation (591)
Complete response letters (39)
COVID-19 (1110)
CRISPR (87)
C-suite (550)
Cystic fibrosis (113)
Data (4328)
Denatured (15)
Depression (92)
Diabetes (254)
Diagnostics (1404)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (187)
Drug pricing (48)
Drug shortages (3)
Duchenne muscular dystrophy (213)
Earnings (31724)
Editorial (25)
Employer branding (4)
Employer resources (29)
Events (51807)
Executive appointments (621)
FDA (7650)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (981)
Gene editing (184)
Generative AI (21)
Gene therapy (487)
GLP-1 (504)
Government (1158)
Grass and pollen (3)
Guidances (167)
Healthcare (6648)
HIV (25)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (190)
Immuno-oncology (39)
Indications (66)
Infectious disease (1218)
Inflammatory bowel disease (155)
Inflation Reduction Act (10)
Influenza (39)
Intellectual property (166)
Interviews (18)
IPO (7370)
IRA (12)
Job creations (872)
Job search strategy (130)
JPM (40)
Kidney cancer (9)
Labor market (22)
Layoffs (244)
Leadership (9)
Legal (1405)
Liver cancer (41)
Longevity (11)
Lung cancer (419)
Lymphoma (248)
Machine learning (24)
Management (7)
Manufacturing (376)
MASH (130)
Medical device (2678)
Medtech (2687)
Mergers & acquisitions (6640)
Metabolic disorders (724)
Multiple sclerosis (102)
NASH (13)
Neurodegenerative disease (229)
Neuropsychiatric disorders (70)
Neuroscience (1949)
Neurotech (1)
NextGen: Class of 2026 (2037)
Non-profit (874)
Now hiring (30)
Obesity (329)
Opinion (125)
Ovarian cancer (131)
Pain (102)
Pancreatic cancer (161)
Parkinson's disease (232)
Partnered (12)
Patents (302)
Patient recruitment (327)
Peanut (43)
People (26699)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15504)
Phase 2 (20340)
Phase 3 (12902)
Pipeline (3255)
Policy (90)
Postmarket research (859)
Preclinical (6553)
Press Release (33)
Prostate cancer (145)
Psychedelics (50)
Radiopharmaceuticals (238)
Rare diseases (653)
Real estate (1456)
Recruiting (12)
Regulatory (9952)
Reports (19)
Research institute (984)
Resumes & cover letters (18)
Rett syndrome (24)
RNA editing (21)
RSV (17)
Schizophrenia (123)
Series A (182)
Series B (136)
Service/supplier (1)
Sickle cell disease (82)
Special edition (18)
Spinal muscular atrophy (121)
Sponsored (16)
Startups (2009)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (18)
The Weekly (62)
Vaccines (334)
Venture capital (69)
Weight loss (173)
Women's health (25)
Worklife (2)
Date
Last 7 days (344)
Last 30 days (1138)
Last 365 days (17834)
2026 (1655)
2025 (18135)
2024 (20603)
2023 (22478)
2022 (26958)
2021 (27959)
2020 (23530)
2019 (16337)
2018 (11797)
2017 (13828)
2016 (11922)
2015 (14447)
2014 (10444)
2013 (7544)
2012 (7594)
2011 (7697)
2010 (7498)
Location
Africa (156)
Alabama (67)
Alaska (2)
Arizona (71)
Arkansas (5)
Asia (18324)
Australia (3122)
California (7087)
Canada (1843)
China (773)
Colorado (247)
Connecticut (256)
Delaware (235)
Europe (39441)
Florida (903)
Georgia (209)
Hawaii (2)
Idaho (17)
Illinois (396)
India (35)
Indiana (160)
Iowa (8)
Japan (224)
Kansas (80)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (736)
Massachusetts (5584)
Michigan (110)
Minnesota (247)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (32)
New Hampshire (22)
New Jersey (1653)
New Mexico (13)
New York (1764)
North Carolina (826)
North Dakota (7)
Northern California (3480)
Ohio (177)
Oklahoma (11)
Oregon (24)
Pennsylvania (1276)
Puerto Rico (9)
Rhode Island (25)
South America (216)
South Carolina (10)
Southern California (2811)
Tennessee (40)
Texas (906)
United States (23367)
Utah (98)
Virginia (136)
Washington D.C. (37)
Washington State (593)
West Virginia (1)
Wisconsin (46)
283,158 Results for "strand therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Strand Therapeutics Appoints Jeb Keiper to Board of Directors
December 3, 2025
·
4 min read
Press Releases
Strand Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 16, 2025
·
2 min read
Press Releases
Strand Therapeutics Appoints Dr. Jason J. Luke as Chief Medical Officer
August 21, 2025
·
3 min read
Press Releases
Strand Therapeutics Promotes Prashant Nambiar to Chief Scientific Officer and Appoints Ethan Cash as Senior Vice President, Head of Portfolio Management and Program Development
November 6, 2025
·
4 min read
Insights
Programmable RNA 2.0: Beyond the First mRNA Revolution
In this episode of Denatured, Jennifer C. Smith-Parker speaks to Erik Digman Wiklund, CEO of Circio and Jacob Becraft, Co-founder and CEO of Strand Therapeutics. They discuss how post-COVID, emerging platforms like circular and logic circuit RNA are expanding the field’s therapeutic horizons.
February 5, 2026
·
1 min read
·
Jennifer Smith-Parker
Press Releases
Strand Therapeutics Raises $153 Million Series B Financing to Further Advance Programmable mRNA Therapeutic Pipeline
August 7, 2025
·
5 min read
Press Releases
Breakthrough Study by LinusBio Suggests Path to First Biochemical Biomarker for ALS, Detected in a Single Hair Strand
September 10, 2025
·
3 min read
Rare diseases
IRA Leaves Orphan Drugs Stranded Even as Regulators Promise Progress
The Inflation Reduction Act includes an exemption for orphan drugs for a single indication, but experts say this is far from sufficient to maintain momentum in the rare disease space.
June 23, 2025
·
7 min read
·
Heather McKenzie
Genetown
Strand Therapeutics Announces First Patient Dosed with Programmable mRNA Therapy STX-001 in Phase 1 Trial for Solid Tumors
Strand Therapeutics today announced the first patient has been dosed in their Phase 1, first-in-human trial of STX-001.
May 30, 2024
·
3 min read
Press Releases
Strand Therapeutics Announces Initial First-in-human Phase 1 Data for STX-001 in Patients with Advanced Solid Tumors at The 2025 ASCO Annual Meeting
May 28, 2025
·
6 min read
1 of 28,316
Next
